The Presidential Daily Brief


  1. Pink pill

    Thumb’s Up for Women’s Libido Drug

    It’s not through the approval process yet, but it’s coming close. The little pink pill, known as flibanserin, was just approved 18-6 by an advisory panel. It’s been rejected twice by the FDA over its side effects and ability to actually increase libido — but that’s caused controversy, as Sprout Pharmaceuticals, which makes the drug, claims that it’s being held to a higher standard than drugs aimed at lifting male libidos. The FDA denies the charges, and will probably approve flibanserin — though they aren’t bound by the panel’s decision, they normally follow their recommendations.  

This story is part of The Presidential Daily Brief

view full edition